142 related articles for article (PubMed ID: 34520441)
1. Switch to INSTIs, but Not Long-Term Stable INSTIs, Is Associated With Excess Weight Gain in People Living With HIV.
Sørensen EW; Gelpi M; Knudsen AD; Benfield T; Mocroft A; Nielsen SD
J Acquir Immune Defic Syndr; 2021 Dec; 88(5):e36-e38. PubMed ID: 34520441
[No Abstract] [Full Text] [Related]
2. INSTIs and weight gain in pregnancy.
Bengtson AM; Myer L; Abrams EJ; Jao J; Cu-Uvin S
Lancet HIV; 2020 Oct; 7(10):e663-e665. PubMed ID: 33010239
[No Abstract] [Full Text] [Related]
3. Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy.
Shah S; Hill A
Curr Opin Infect Dis; 2021 Feb; 34(1):16-24. PubMed ID: 33278177
[TBL] [Abstract][Full Text] [Related]
4. Weight Change When Initiating, Switching to, and Discontinuing Integrase Strand Transfer Inhibitors in People Living with HIV.
Tieosapjaroen W; Chow EPF; Fairley CK; Hoy J; Aguirre I; Ong JJ
AIDS Patient Care STDS; 2023 Mar; 37(3):131-137. PubMed ID: 36809049
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.
Lake JE; Wu K; Bares SH; Debroy P; Godfrey C; Koethe JR; McComsey GA; Palella FJ; Tassiopoulos K; Erlandson KM
Clin Infect Dis; 2020 Dec; 71(9):e471-e477. PubMed ID: 32099991
[TBL] [Abstract][Full Text] [Related]
6. Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weight.
McMahon C; Trevaskis JL; Carter C; Holsapple K; White K; Das M; Collins S; Martin H; Burns-Naas LA
PLoS One; 2020; 15(2):e0229617. PubMed ID: 32109250
[TBL] [Abstract][Full Text] [Related]
7. HIV integrase inhibitors: 20-year landmark and challenges.
Métifiot M; Marchand C; Pommier Y
Adv Pharmacol; 2013; 67():75-105. PubMed ID: 23885999
[TBL] [Abstract][Full Text] [Related]
8. Weight gain and integrase inhibitors.
Eckard AR; McComsey GA
Curr Opin Infect Dis; 2020 Feb; 33(1):10-19. PubMed ID: 31789693
[TBL] [Abstract][Full Text] [Related]
9. Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors.
O'Halloran JA; Cooley SA; Strain JF; Boerwinkle A; Paul R; Presti RM; Ances BM
AIDS; 2019 Jul; 33(9):1477-1483. PubMed ID: 31008801
[TBL] [Abstract][Full Text] [Related]
10. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection.
Zhao AV; Crutchley RD; Guduru RC; Ton K; Lam T; Min AC
Retrovirology; 2022 Oct; 19(1):22. PubMed ID: 36273165
[TBL] [Abstract][Full Text] [Related]
11. Variability in HIV-1 Integrase Gene and 3'-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy.
Acharya A; Tagny CT; Mbanya D; Fonsah JY; Nchindap E; Kenmogne L; Jihyun M; Njamnshi AK; Kanmogne GD
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106437
[No Abstract] [Full Text] [Related]
12. Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?
Brooks KM; Sherman EM; Egelund EF; Brotherton A; Durham S; Badowski ME; Cluck DB
Pharmacotherapy; 2019 May; 39(5):576-598. PubMed ID: 30860610
[TBL] [Abstract][Full Text] [Related]
13. Weight change with integrase strand transfer inhibitors among virally suppressed Thai people living with HIV.
Han WM; Kerr SJ; Avihingsanon A; Boettiger DC
J Antimicrob Chemother; 2022 Nov; 77(12):3242-3247. PubMed ID: 36101517
[TBL] [Abstract][Full Text] [Related]
14. Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy: Republication.
Shah S; Hill A
Curr Opin HIV AIDS; 2021 Mar; 16(2):106-114. PubMed ID: 33625041
[TBL] [Abstract][Full Text] [Related]
15. Drug safety profile of integrase strand transfer inhibitors.
Gutierrez Mdel M; Mateo MG; Vidal F; Domingo P
Expert Opin Drug Saf; 2014 Apr; 13(4):431-45. PubMed ID: 24597519
[TBL] [Abstract][Full Text] [Related]
16. Real-world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors.
Fuller T; Fragoso da Silveira Gouvêa MI; Benamor Teixeira ML; Ferreira Medeiros A; Amorim da Silva P; Medeiros Braga C; Constan Werneck Sant'anna M; de Mattos Salgueiro M; da Silveira Bressan C; Mendes-Silva W; João EC
HIV Med; 2023 Mar; 24(3):301-310. PubMed ID: 36065478
[TBL] [Abstract][Full Text] [Related]
17. Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor.
Piacentini D; Lanzafame M; Rizzardo S; Chiesi S; Lattuada E; Mehrabi S; Zamboni G; Mazzi R; Tacconelli E; Vento S
Int J STD AIDS; 2020 Dec; 31(14):1407-1410. PubMed ID: 33081650
[TBL] [Abstract][Full Text] [Related]
18. Relationship between weight gain and insulin resistance in people living with HIV switching to integrase strand transfer inhibitors-based regimens.
Milic J; Renzetti S; Ferrari D; Barbieri S; Menozzi M; Carli F; Dolci G; Ciusa G; Mussini C; Calza S; Guaraldi G
AIDS; 2022 Oct; 36(12):1643-1653. PubMed ID: 35727163
[TBL] [Abstract][Full Text] [Related]
19. An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus.
Chow W; Donga P; Côté-Sergent A; Rossi C; Lefebvre P; Lafeuille MH; Emond B; Hardy H
Curr Med Res Opin; 2020 Aug; 36(8):1313-1323. PubMed ID: 32459155
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy in older people with HIV.
Richterman A; Sax PE
Curr Opin HIV AIDS; 2020 Mar; 15(2):118-125. PubMed ID: 31990705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
